Utilizing combinatorial engineering to develop Tie2 targeting antagonistic angiopoetin-2 ligands as candidates for anti-angiogenesis therapy

Tomer Shlamkovich(Ben-Gurion University of the Negev), Niv Papo(Ben-Gurion University of the Negev)
Oncotarget
April 4, 2017
Cited by 4


Related Papers